Accrol Group Holdings plc (LON:ACRL) is the topic of conversation when Mike Allen, Head of Research at Zeus Capital joins DirectorsTalk. With the company producing is half year trading update Mike talks us...

Accrol Group Holdings plc (LON:ACRL), the UK's leading independent tissue converter, has announced its results for the six months ended 31 October 2020. Summary of progress The Group's progress continues...

Accrol Group Holdings plc (LON:ACRL) has announced that, as part of the Group's Half Yearly Results roadshow, the management will host an online investor presentation and Q&A session. This will...

Accrol Group Holdings plc (LON:ACRL), one of the UK's leading independent tissue converters, has announced that it will release its Half Year Results for the six months to 31 October...

Accrol Group Holdings plc (LON:ACRL), one of the UK's leading independent tissue converters, has announced that following the successful acquisition of Leicester Tissue Company in November 2020, the Group's CEO...

Accrol Group Holdings plc (LON:ACRL), one of the UK's leading independent tissue converters, has announced that it has reached formal agreement with Richard Newman FCA to take up the position...

Zeus Capital’s Mike Allen discusses Accrol Group Holdings plc in this exclusive interview with DirectorsTalk.

Accrol Group Holdings plc (LON:ACRL) is the topic of conversation when Mike Allen, Head of Research at Zeus Capital joins DirectorsTalk. Mike shares his thoughts on the LTC acquisition, how this factors into...

Accrol Group Holdings plc (LON:ACRL), a leading independent tissue converter in the UK, has announced that the Final Condition has now been satisfied and the Acquisition has now completed. The capitalised...

We believe Accrol Group Holdings plc (LON:ACRL) acquisition of LTC represents a transformational transaction which the potential to consolidate the Group’s leading position in the private label tissue market to...